Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), 2-propenoate

Repeated dose toxicity: inhalation

Administrative data

Endpoint:

short-term repeated dose toxicity: inhalation

Data waiving:

study scientifically not necessary / other information available

Justification for data waiving:

other:

Cross-reference

Cross-reference 1

Reason / purpose for cross-reference:

data waiving: supporting information

Reference

Endpoint:

short-term repeated dose toxicity: oral

Remarks:

Combined repeated dose and reproduction / developmental screening

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2012 -2013

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Qualifier:

according to guideline

Guideline:

OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)

Deviations:

no

Qualifier:

according to guideline

Guideline:

other: EPA OPPTS 870.3650, adopted July 2000

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Limit test:

no

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

Test animals
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH (male and female animals were derived from different litters to rule out mating of siblings)
- Age at study initiation: 10-11 wks
- Weight at study initiation: on average: Males: 335g; Females: 197g
- Fasting period before study: no
- Housing: single (except during mating and during lactation) in Markrolon type M III cages
- Diet (e.g. ad libitum): ground Kliba maintenance diet mouse-rat “GLP”, meal ad lib.
- Water (e.g. ad libitum): ad lib.
- Acclimation period: app. 1 week

Environmental conditions
- Temperature (°C): 20-24°C
- Humidity (%): 30-70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12h/12h

Route of administration:

oral: drinking water

Details on route of administration:

Not available

Vehicle:

corn oil

Details on oral exposure:

Preparation of dosing soltuions:
- The desired amount of test substance was weighed, and corn oil was added up to the correct volume. To prepare a homogenous suspension, the mixture was stirred with a magnetic stirrer also during administration. The test substance preparations were produced at least once a week and were stored at room temperature. The administration volume was 4 mL/kg bw.
Vehicle:
- Justification for use and choice of vehicle (if other than water): The test substance is poorly soluble in water, but forms a homogenous suspension in corn oil, which is also non-toxic to rats.
- Concentration in vehicle: 0, 1.25, 3.75 and 12.5 g/100mL

Analytical verification of doses or concentrations:

yes

Details on analytical verification of doses or concentrations:

Homogeneity, stability and concentration control analyses of the test substance preparations were performed in all concentrations at the start of the administration period. Additionally, samples from all concentrations as reverse samples for concentration control analysis were taken at the end of the study. The concentration control analyses of all concentrations revealed that the values were in the expected range of the target concentrations, i.e. were always in a range of about 90.0-110.0% of the nominal concentrations. Considering the low relative standard deviation in the homogeneity analysis, it can be concluded that the the test substance was distributed homogeneously in corn oil.

Duration of treatment / exposure:

Males: 35 days
Females: 56 days

Frequency of treatment:

Daily (except to animals being in labor)

Dose / conc.:

0 mg/kg bw/day (actual dose received)

Dose / conc.:

50 mg/kg bw/day (actual dose received)

Dose / conc.:

150 mg/kg bw/day (actual dose received)

Dose / conc.:

500 mg/kg bw/day (actual dose received)

No. of animals per sex per dose:

10

Control animals:

yes, concurrent no treatment

Details on study design:

Dose selection rationale:
The selection of doses was based on the results of a test study in female Wistar rats (BASF project No. 10C0457/11S163) conducted at dose levels of 0, 600 and 1000 mg/kg bw/d. In this study, a NOAEL was not established due to erosions and ulcerations in the stomach of different animals at both dose levels of 600 and 1000 mg/kg bw/d as well as clinical findings like poor general condition, piloerection and body weight loss after 1 week of treatment.

Positive control:

No

Observations and examinations performed and frequency:

Cage side observations: Yes
- Time schedule: twice daily on workdays, daily on weekends and public holidays
- Cage side observations: check for moribund animals, pertinent behavioral changes, signs of overt toxicity, parturation, littering and lactation behavior of the dams

Detailed clinical observations: Yes
- Time schedule: prior to the first administration, weekly thereafter
- The following parameters were examined: abnormal behavior during “handling”, fur, skin, posture, salivation, respiration, activity/arousal level, tremors, convulsions, abnormal movements, impairment of gait, lacrimation, palpebral closure, exophthalmus, feces (appearance/consistency), urine, pupil size

Body weight: Yes
- Time schedule for examinations: day 0, weekly thereafter with the following exceptions for females: during the mating period the parental females were weighed on the day of positive evidence of sperm (GD 0) and on GD 7, 14 and 20. Females with litter were weighed on the day of parturition (PND 0) and on PND 4.

Food consumption: Yes (once weekly), except during mating

Water consumption: Monitored by daily visual inspection

Other:
- Functional observation battery and motor activity measurement of 5 males and females per group 2 days prior to sacrifice
- Urinanalysis in 5 males and females per group one day prior to necropsy
- Clinicochemical and hematological examinations 5 males and females on the day of necropsy after fasting for 16h

Sacrifice and pathology:

Sacrifice:
- Male animals: All surviving animals on day 36
- Maternal animals: All surviving animals on day 57

Gross necropsy
- Gross necropsy consisted of external and internal examinations

Histopathology / Organ weights
The following tissues were weighed
- in all animals: epididymides, testes, and stages of spermatogenesis
- in 5 males and females of each group: adrenal glands, brain, heart, kidneys, liver, spleen, thymus
The uteri of all cohabited female parental animals were examined for the presence and number of implantation sites. The uteri of apparently non-pregnant animals or empty uterus horns were placed in 1% ammonium sulfide solutions for about 5 minutes in order to be able to identify early resorptions or implantations.
The following tissues were examined histotechnically in at least 5 animals per sex of the control and high dose group (reproductive organs were examined in all high dose and control animals):
adrenal glands, gross lesions (all affected animals in all dosage groups), bone marrow (femur), brain, cecum, cervix, coagulation glands, colon, duodenum, epididymides, heart, ileum, jejunum, kidneys, liver, lungs, lymph nodes (auxillary and mesenteric), ovaries, oviducts, prostate gland, peyer's patches, rectum, sciatic nerve, seminal vesicles, spinal cord, spleen, stomach, testes, thymus, thyroid glands, trachea, urinary bladder, uterus, vagina.

Other examinations:

Reproductive performance: see chapter 7.8.1

Statistics:

Not available

Clinical signs:

effects observed, treatment-related

Description (incidence and severity):

Almost all male and most female animals of the high dose group showed salivation within 2 hours after the administration on several days of the study. Salivation within 2 hours after treatment was also seen in several mid dose male and female animals. From the temporary, short appearance immediately after dosing it was concluded that salivation was induced by a bad taste of the test substance or local affection of the upper digestive tract.

Mortality:

mortality observed, non-treatment-related

Description (incidence):

One female animal (in the 500 mg/kg bw/day group) was sacrificed in a moribund condition on study day 51 (GD 24). Vaginal discharge was observed on GDs 23-24 in this animal, which showed poor general state and was unable to deliver on GD 24. This animal was sacrificed moribund on the same day. According to the pathological results the findings were assessed as being incidental and not related to treatment.

Body weight and weight changes:

no effects observed

Food consumption and compound intake (if feeding study):

no effects observed

Food efficiency:

not examined

Water consumption and compound intake (if drinking water study):

no effects observed

Ophthalmological findings:

not examined

Haematological findings:

no effects observed

Clinical biochemistry findings:

no effects observed

Urinalysis findings:

no effects observed

Behaviour (functional findings):

effects observed, non-treatment-related

Description (incidence and severity):

Neurobehaviour:
All deviations from "zero" values were equally distributed between all groups including controls; hence the finding were assessed as being incidental and not treatment related.

Immunological findings:

not examined

Organ weight findings including organ / body weight ratios:

no effects observed

Description (incidence and severity):

All mean weight parameters (absolute and relative) did not show significant differences when compared to the control groups.

Gross pathological findings:

effects observed, non-treatment-related

Description (incidence and severity):

All gross lesions noted were single observations and they were regarded to have developed spontaneously and unrelated to compound and treatment.

Neuropathological findings:

not examined

Histopathological findings: non-neoplastic:

effects observed, non-treatment-related

Description (incidence and severity):

All findings were considered to be incidental or spontaneous in origin and without any relation to treatment.
One high dose female animal that was sacrificed in a moribund state revealed a decidual reaction with consequent inflammation of the uterus. Decidual reaction is a proliferation of decidual cells (tissue of endometrial origin lining of the uterus, which is in contact with the fetal membranes and the placental plate). They often are assiocated with inflammation as observed in this animal. The local inflammation in the uterus can lead to disturbance of the general condition or, if the inflammation is spreading, sepsis. This was regarded to be the reason for the moribund state of this animal but was not regarded to be treatment-related.

Histopathological findings: neoplastic:

no effects observed

Description (incidence and severity):

Reproductive toxicity results: see chapter 7.8.1

Key result

Dose descriptor:

NOAEL

Remarks:

systemic toxicity

Effect level:

>= 500 mg/kg bw/day (actual dose received)

Based on:

test mat.

Sex:

male/female

Remarks on result:

not determinable due to absence of adverse toxic effects

Key result

Critical effects observed:

no

Conclusions:

Under the study conditions, the rat NOAEL for systemic effects was established at >=500 mg/kg bw/day for females and males.

Executive summary:

A study was conducted to determine the repeated dose toxicity of the test substance according to OECD guideline 422 and EPA OPPTS 870.3650, in compliance with GLP. The general systemic toxic potential of the substance to Wistar rats was assessed by daily oral administration (gavage). Males were dosed for 35 days and females for 56 days. Groups comprising 10 male and 10 female rats received the test substance at doses of 0, 50, 150 or 500 mg/kg bw/ day in corn oil. A detailed clinical observation was performed in all animals before initial test substance administration and thereafter at weekly intervals. Food consumption of the F0 parents was determined once weekly during premating. In dams food consumption was determined for gestation days 0-7, 7-14, 14-20 and lactation days 1-4. Body weights of F0 parents were determined once a week, in males throughout the study and in females during premating and mating. During gestation and lactation period, F0 females were weighed on gestation days (GD) 0, 7, 14 and 20, after the day of parturition (postnatal day [PND] 0) and on PND 4. The pups were sexed and examined for macroscopically evident changes on PND 0. They were weighed on PND 1 and on PND 4. Their viability was recorded. At necropsy on PND 4, all pups were sacrificed under isoflurane anesthesia with CO2 and examined macroscopically for external and visceral findings. Clinicochemical and hematological examinations as well as urinalyses were performed in 5 animals per sex and group towards the end of the administration period. All F0 parental animals were sacrificed by decapitation, under isoflurane anesthesia, and were assessed by gross pathology. Weights of selected organs were recorded and a histopathological examination was performed. One female animal of test group 500 mg/kg bw/day was sacrificed in a moribund condition on study day 51 (GD 24). Vaginal discharge was observed on GDs 23-24 in this animal, which showed poor general state and was unable to deliver on GD 24. This animal was sacrificed moribund on the same day. According to the pathological results the findings were assessed as being incidental and not related to treatment. Almost all male and most female animals of the high dose group showed salivation within 2 hours after the administration on several days of the study. Salivation within 2 hours after treatment was also seen in several mid dose male and female animals. From the temporary, short appearance immediately after dosing it was concluded that salivation was induced by a bad taste of the test substance or local affection of the upper digestive tract. No test substance-related changes in body weight or body weight gain were observed for all test groups. For food and water consumption, no test substance-related, adverse findings were noted. No treatment-related changes among hematological, clinical chemistry and urinalysis parameters were observed. All deviations from "zero" values observed following neurobehavioural examination were equally distributed between all groups including controls; the findings were assessed as being incidental and not treatment related. All mean organ weight parameters (absolute and relative) did not show significant differences when compared to the control groups. All gross lesions noted were single observations and they were regarded to have developed spontaneously and unrelated to compound and treatment. All histopathology (non-neoplastic) findings were considered to be incidental or spontaneous in origin and without any relation to treatment. The high dose female animal that was sacrificed in a moribund state revealed a decidual reaction with consequent inflammation of the uterus. Decidual reaction is a proliferation of decidual cells (tissue of endometrial origin lining of the uterus, which is in contact with the fetal membranes and the placental plate). They are often assiocated with inflammation as observed in this animal. The local inflammation in the uterus can lead to disturbance of the general condition or, if the inflammation is spreading, sepsis. This was regarded to be the reason for the moribund state of this animal but was not regarded to be treatment-related. Under the study conditions, the rat NOAEL for systemic effects was established at >=500 mg/kg bw/day for females and males (BASF, 2013).

Cross-reference 2

Reason / purpose for cross-reference:

data waiving: supporting information

Reference

Endpoint:

vapour pressure

Type of information:

experimental study

Adequacy of study:

other information

Study period:

2016

Reliability:

3 (not reliable)

Rationale for reliability incl. deficiencies:

other: Guideline study but result not reliable due to methodological difficulties.

Qualifier:

according to guideline

Guideline:

OECD Guideline 104 (Vapour Pressure Curve)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU Method A.4 (Vapour Pressure)

Deviations:

no

GLP compliance:

not specified

Type of method:

effusion method: Knudsen cell

Key result

Temp.:

ca. 20 °C

Vapour pressure:

ca. 0.001 Pa

Remarks on result:

other: calculated from the regression equation

Key result

Temp.:

ca. 25 °C

Vapour pressure:

ca. 0.001 Pa

Remarks on result:

other: calculated from the regression equation

Temp.:

ca. 30 °C

Vapour pressure:

ca. 0.001 Pa

Key result

Temp.:

ca. 45 °C

Vapour pressure:

ca. 0.001 Pa

Observations:

- At the measurements of experiment 3 (nominal temperature 60°C) the test substance was polymerized in all vials, therefore no additional experiments at higher temperatures were conducted.

- As the test substance polymerized at 60 °C these experiments were not taken into account. Only the measurements at 30 and 45 °C were used for the estimation of the vapour pressure. The very first measurement at 30 °C is not taken into account, because the higher vapour pressure is likely caused by impurities with a higher vapour pressure. The second measurement at 45°C yielded an increase in weight which is scientifically not possible. Therefore this measurement is not taken into account either.

- As a valid calculation with a minimum of three data points on base of the measured weight losses is not possible, a worst case approach is to consider the highest vapour pressure, derived from all measurements, as limit value.

- The limit value of the vapour pressure of the test substance was stated as 1.43 * 10-03 Pa at 45 °C. This value is the highest value found in the experiment at nominal temperature 45 °C).

Conclusions:

Under the study conditions, the limit vapour pressure of the test substance was determined to be 1.43E-03 Pa at 45°C (effusion method: Knudsen cell).

Executive summary:

A study was conducted to determine the vapour pressure of the test substance using Knudsen cell effusion method according to OECD Guideline 104 and EU Method A.4. The test substance was weighed into the 4 Knudsen cells, which were set into vacuum chamber at 10-05 Pa or lower followed by measurements at 30, 45 and 60°C. As the test substance polymerized at 60°C, only the measurements at 30 and 45°C were used for the estimation of the vapour pressure. The very first measurement at 30°C was not taken into account, because the higher vapour pressure was likely caused by impurities with a higher vapour pressure. The second measurement at 45°C yielded an increase in weight which was scientifically not possible. Therefore this measurement was not taken into account either.

The measured values for temperature and vapour pressure were evaluated as follows: 1.12E-03 and 1.24E-03 at 30 and 45°C, respectively. As the vapour pressure values were correlated by a linear relation, the vapour pressures of the test substance at 20 and 25 °C were calculated to be 1.04E-03 and 1.08E-03 Pa from the regression equation. As a valid calculation with a minimum of three data points on base of the measured weight losses was not possible, a worst case approach is to consider the highest vapour pressure, derived from all measurements, as limit value. As a valid calculation with a minimum of three data points on basis of the measured weight losses was not possible, a worst case approach was to consider the highest vapour pressure, derived from all measurements, as limit value. The limit value of the vapour pressure of the test substance was stated as 1.43E-03 Pa at 45 °C. This value is the highest value found in the experiment at nominal temperature 45°C (Krebs, 2016).